2024
Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells before and after anti-tuberculosis treatment
Fang Y, Tang Y, Luo Q, Wang N, Tang L, Yang X, You X, Wang Y, Liang L, Zhang J, Su B, Sha W. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells before and after anti-tuberculosis treatment. European Journal Of Medical Research 2024, 29: 147. PMID: 38429734, PMCID: PMC10908161, DOI: 10.1186/s40001-024-01713-x.Peer-Reviewed Original ResearchConceptsLatent TB infectionAnti-TB treatmentPulmonary TB patientsT cellsHealthy controlsPTB patientsTB patientsActive pulmonary TB patientsLTBI casesAnti-tuberculosis treatmentAnti-TB regimenErythrocyte sedimentation rateC-reactive proteinArea under receiver operating characteristic curveESAT-6/CFP-10Treatment courseProtein 10TB infectionCFP-10Severity scoreBackgroundThe aimAnti-tuberculosisPatientsMonthsTreatment
2014
Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey
Menzies H, Moalosi G, Anisimova V, Gammino V, Sentle C, Bachhuber M, Bile E, Radisowa K, Kachuwaire O, Basotli J, Maribe T, Makombe R, Shepherd J, Kim B, Samandari T, El-Halabi S, Chirenda J, Cain K. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey. The International Journal Of Tuberculosis And Lung Disease 2014, 18: 1026-1033. PMID: 25189548, PMCID: PMC5531285, DOI: 10.5588/ijtld.13.0749.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntitubercular AgentsBotswanaChildChild, PreschoolDrug Resistance, Multiple, BacterialFemaleHealth Care SurveysHumansMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisSputumTime FactorsTreatment OutcomeTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryYoung AdultConceptsAnti-tuberculosis drug resistanceMultidrug-resistant tuberculosisPrevious anti-tuberculosis treatmentAnti-tuberculosis treatmentNew TB patientsDrug resistance surveyTB patientsDrug susceptibility testingDrug resistanceNew sputum smear-positive TB patientsAnti-tuberculosis drug susceptibility testingSputum smear-positive TB patientsNational drug resistance surveyHigh TB burden countriesMDR-TB diagnosisPositive TB patientsDrug-resistant TBTB burden countriesResistance surveyEmergence of resistanceTB controlBurden countriesDST resultsNew patientsMycobacterial cultureImproved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial
Padayatchi N, Abdool Karim SS, Naidoo K, Grobler A, Friedland G. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial. The International Journal Of Tuberculosis And Lung Disease 2014, 18: 147-154. PMID: 24429305, PMCID: PMC4770013, DOI: 10.5588/ijtld.13.0627.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisMDR-TB patientsSequential treatment armAnti-tuberculosis treatmentAntiretroviral treatmentTreatment armsFirst-line anti-tuberculosis treatmentMultidrug-resistant tuberculosis patientsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionOut-patient clinicDrug susceptibility resultsSAPiT trialTuberculosis patientsClinical outcomesEarly initiationTherapeutic effectVirus infectionMortality ratePatientsTherapeutic outcomesSmall sample sizeTreatmentSusceptibility resultsTuberculosis
2013
Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova
Jenkins HE, Ciobanu A, Plesca V, Crudu V, Galusca I, Soltan V, Cohen T. Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova. The International Journal Of Tuberculosis And Lung Disease 2013, 17: 373-380. PMID: 23407226, PMCID: PMC3710709, DOI: 10.5588/ijtld.12.0464.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntitubercular AgentsContinuity of Patient CareFemaleHumansInstitutionalizationLeast-Squares AnalysisLinear ModelsMaleMedication AdherenceMoldovaMultivariate AnalysisPatient DischargePrisonersProportional Hazards ModelsRetrospective StudiesRisk FactorsSocioeconomic FactorsTime FactorsTreatment OutcomeTuberculosisConceptsMultidrug-resistant tuberculosisMDR-TB patientsRisk factorsHighest MDR-TB ratesDrug resistanceGreater lung pathologyMDR-TB ratesAnti-tuberculosis treatmentIndependent risk factorHuman immunodeficiency virusTB drug resistanceContinuity of careRoutine surveillance dataTuberculosis patientsResistant tuberculosisImmunodeficiency virusLung pathologyTreatment adherenceRetrospective analysisHigh riskPatientsSociodemographic factorsCommunity careSurveillance dataStudy period
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply